Companies partner to perform trials of antimicrobial topical treatmentJanuary 9, 2019Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for new topical treatments based on Artilysin, a new antimicrobial platform technology.
SPONSORED CONTENTTherapeutic skin support at every ageHill’s Prescription Diet Derm Complete is formulated to support the skin barrier against environmental irritants, year round. + Tell Me More